Development of a Scale for Cancer Patients' Willingness to Voluntarily Participate in Drug Clinical Trials

Launched by SUN YAT-SEN MEMORIAL HOSPITAL OF SUN YAT-SEN UNIVERSITY · Nov 6, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how willing cancer patients are to participate in drug clinical trials. Researchers are trying to create a scale, which is like a measurement tool, to help assess this willingness more effectively. The study is currently looking for participants who are between 18 and 80 years old and have a clear diagnosis of a tumor. It’s important that these patients can understand and respond to questions, as well as volunteer to take part in the study by signing an informed consent form.

If you join this study, you’ll be asked to share your thoughts about participating in clinical trials, which are research studies that test new treatments. The researchers are particularly interested in those who have already gone through the process of learning about a clinical trial, whether or not they decided to participate. This trial is designed to be inclusive, but it won’t accept individuals who may have difficulty understanding the questions or are in vulnerable situations, such as minors or those with severe health challenges. Your participation could help improve how we understand patient willingness in future cancer research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18-80 years old (including boundary values).
• • 2. Tumor patients with clear diagnosis.
• • 3. Whether they finally sign the informed consent form of one drug clinical trial or not, and whether they are finally enrolled in one drug clinical trial or not, patients who have undergone the informed consent process of drug clinical trials conducted by clinicians can be enrolled in this study.
• • 4. Volunteer to participate in this study and sign an informed consent form.
• Exclusion Criteria:
• • 1. Patients with unclear consciousness.
• • 2. Patients who are unable to correctly understand and answer questions.
• • 3. Vulnerable subjects include: students and subordinates of researchers, military personnel, prisoners, patients with incurable diseases, patients in critical situations, those admitted to welfare institutions, homeless individuals, minors, and those who are unable to provide informed consent.